aTYR PHARMA (ATYR) Current Leases (2022 - 2026)
aTYR PHARMA's Current Leases came in at $518,000 for Q2 2026, down 7.8% from $562,000 a year earlier and down 13.1% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Current Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, aTYR PHARMA's Current Leases was $630,000, up 16.5% from FY2024.
- Current Leases has increased in each of the last three years, with a three-year compound annual growth rate of 33.6% (FY2022 to FY2025).
- Going back by year, Current Leases was $541,000 in FY2024 (+8.9%), $497,000 in FY2023 (+88.3%) and $264,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Current Leases since Q2 2024.
- Year-over-year, Current Leases increased in seven of the last eight quarters, with growth averaging 9.7%.
- The fastest year-over-year change in Current Leases over five years came in Q2 2023 (growth of 532.9%), and the weakest in Q2 2026 (a decline of 7.8%).
- Business Quant data shows ATYR's Current Leases at $596,000 (Q1 2026), $630,000 (Q4 2025) and $630,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - | 518,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 518,000.00 |
| Mar 31, 2026 | 596,000.00 |
| Dec 31, 2025 | 630,000.00 |
| Sep 30, 2025 | 630,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Dec 31, 2024 | 541,000.00 |
| Sep 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 517,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 497,000.00 |
| Sep 30, 2023 | 459,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | 420,000.00 |
| Dec 31, 2022 | 264,000.00 |
| Sep 30, 2022 | 158,000.00 |
| Jun 30, 2022 | 70,000.00 |
API Access
aTYR PHARMA Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();